We’re pleased to share an important milestone in Enlighten Clinical Solutions’ continued investment in security, privacy, and regulatory alignment for life sciences organizations.
This compliance milestone reflects Enlighten Clinical Solutions’ approach to security, privacy, and regulatory alignment.
Enlighten has successfully completed multiple independent audits assessing our security and privacy control environment, including a SOC 2 Type II audit, a HIPAA Security & Breach Notification Rule audit, and a GDPR control design assessment. These evaluations reflect our ongoing commitment to supporting the data protection standards expected by sponsors, CROs, and clinical research organizations.
What We Announced
As part of our security and compliance program, Enlighten completed the following independent assessments:
SOC 2 Type II audit, validating the operating effectiveness of our security controls over an extended audit period
HIPAA Security & Breach Notification Rule audit, assessing safeguards designed to protect electronic protected health information (ePHI)
GDPR control design assessment, validating the design of privacy controls aligned with applicable GDPR requirements
Together, these assessments provide independent validation of the design and operation of key security, privacy, and governance controls supporting our platform.
Why This Matters
Clinical research organizations increasingly rely on technology platforms to manage sensitive trial data and operational workflows. Independent audits and assessments help demonstrate that systems supporting this work are designed and operated with appropriate security and privacy controls in place.
At Enlighten, compliance is not a one-time event. It is an ongoing program that evolves alongside our technology, our customers’ needs, and the regulatory landscape.
Learn More
You can read the full press release announcing this milestone here: Link to the EIN press release
To learn more about Enlighten’s approach to security, privacy, and regulatory alignment, visit our Compliance & Data Protection page.
